Disclaimer
This is not substantive investment research or a research recommendation, as it does not constitute substantive research or analysis. This material should be considered as general market commentary.
Interest in artificial intelligence (AI) has grown rapidly in the past few years, as the technology has leapt from being the preserve of science fiction to the mainstream. Commentators have become increasingly vocal about the future potential of AI, as well as the fears over the implications of its power. This enthusiasm has spilled over into stock markets, with the technology sector again leading the way in 2023 driven by a number of AI-linked companies. However, whilst the technology to potentially replace humans has seen a boom, the technology designed to save humans—biotech—has had contrasting fortunes. Could this be an opportunity for investors to take profits from technology and rotate in biotech?
Kepler Trust Intelligence provides research and information for professional and private investors. In order to ensure that we provide you with the right kind of content, and to ensure that the content we provide is compliant, you need to tell us what type of investor you are.
Continue
